Literature DB >> 15752165

Mononuclear cell variability and recruitment in non-cytokine-stimulated donors after serial 10-liter leukapheresis procedures.

Erwin F Strasser1, Robert Zimmermann, Volker Weisbach, Jürgen Ringwald, Jürgen Zingsem, Reinhold Eckstein.   

Abstract

BACKGROUND: We introduced monitoring of mononuclear cell (MNC) counts to obtain enhanced donor control and a stable quality of MNC products, because there are limited data available about blood donors after serial leukapheresis (LP) procedures. STUDY DESIGN AND METHODS: In a prospective paired study, 13 male healthy blood donors underwent 10-L LP procedures performed on two apheresis devices by use of two MNC program settings (COBE Spectra, Gambro BCT, SF 250 vs. SF 500; and AS.TEC 204, Fresenius Hemocare, CP 129 vs. CP 194). Donors' pre- and postdonation MNC counts were analyzed by fluorescence-activated cell sorting.
RESULTS: After each 10-L LP procedure, a transient decline (p < 0.05) of CD14+ monocyte and platelet counts appeared in donors. Loss of donors' CD3+ T cells, CD19+ B cells, and CD16+56+ natural killer (NK) cells during MNC collection was partly compensated by cell recruitment. The MNC recruitment factor (RF) seems to be higher with high-yield MNC program settings. Negative correlations (p < 0.01) were noticed between predonation counts and RFs of CD3+ T cells and CD16+56+ NK cells. Four serial 10-L LP procedures did not result in long lasting MNC depletion for donors.
CONCLUSION: MNC recruitment seems to depend on MNC program settings and collected cell yields. Low MNC counts could result in high cell recruitment that may contribute to stable collection results to some degree. Nevertheless, there seems to be a considerable individual variation of MNC recruitment in donors that should be investigated in more detail.

Entities:  

Mesh:

Year:  2005        PMID: 15752165     DOI: 10.1111/j.1537-2995.2005.04202.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.

Authors:  Douglas G McNeel; Thomas A Gardner; Celestia S Higano; Philip W Kantoff; Eric J Small; Mark H Wener; Robert B Sims; Todd DeVries; Nadeem A Sheikh; Robert Dreicer
Journal:  Cancer Immunol Res       Date:  2014-09-04       Impact factor: 11.151

2.  Low-Volume Leukapheresis in Non-Cytokine-Stimulated Donors for the Collection of Mononuclear Cells.

Authors:  Adamma Anyanwu; Nicole Sitzmann; Svetlana Hetjens; Harald Klüter; Patrick Wuchter
Journal:  Transfus Med Hemother       Date:  2018-08-28       Impact factor: 3.747

Review 3.  Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm.

Authors:  James L Gulley; Peter Mulders; Peter Albers; Jacques Banchereau; Michel Bolla; Klaus Pantel; Thomas Powles
Journal:  Oncoimmunology       Date:  2015-12-10       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.